|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
6R01CA148966-06
|
$1
|
$1
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Tpl2 in carcinogenesis-related inflammation
|
2R15CA152907-02
|
$419,137
|
$209,569
|
DECICCO-SKINNER, KATHLEEN
|
AMERICAN UNIVERSITY
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
5R01CA184820-02
|
$399,582
|
$399,582
|
DUBOIS, RAYMOND
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
ESTROGEN RECEPTOR TARGETED TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
|
5K23CA160664-03
|
$132,711
|
$132,711
|
GODOY, GUILHERME
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-02
|
$2,184,998
|
$131,100
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-02
|
$571,122
|
$571,122
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Controlling cancer with aspirin-triggered stimulation of resolution
|
5R01CA170549-04
|
$506,329
|
$506,329
|
PANIGRAHY, DIPAK
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Feasibility of grape seed extract for lung cancer chemoprevention
|
5R21CA173211-03
|
$111,270
|
$111,270
|
MAO, JENNY
|
BIOMEDICAL RESEARCH INSTITUTE OF NEW MEX
|
|
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers
|
5R01CA156186-06
|
$522,033
|
$130,508
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
Towards Development of an in vitro Assay to Personalize Colonic Chemoprevention
|
1R03CA195143-01
|
$87,000
|
$87,000
|
WALI, RAMESH
|
BOSTON MEDICAL CENTER
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$26,779
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
2R01CA138962-07
|
$3,124,816
|
$3,124,816
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Effects of Vitamin D on Mammographic Density and Breast Tissue
|
5R01CA178263-02
|
$469,315
|
$469,315
|
REXRODE, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
2P01CA087969-16
|
$2,457,338
|
$491,468
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathwa
|
1K07CA188126-01A1
|
$144,000
|
$144,000
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
5U54CA163060-05
|
$1,446,550
|
$86,793
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S1
|
$37,026
|
$2,222
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S2
|
$49,999
|
$3,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Oncology Research Career Development Program (CORP)
|
5K12CA076917-18
|
$685,749
|
$68,575
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-25
|
$4,878,887
|
$292,733
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
TIMP3: A Molecular Target of Green Tea Polyphenols
|
1R21CA193080-01
|
$172,369
|
$172,369
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Small Molecule Induction of 15-PGDH: A Target in Colon Cancer Chemoprevention
|
5R01CA168586-03
|
$328,888
|
$328,888
|
LETTERIO, JOHN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplas
|
5U01CA181770-02
|
$542,530
|
$542,530
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
5P50CA150964-05
|
$2,184,997
|
$196,650
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Natural Agent in Prevention of Prostate Cancer
|
1R21CA190921-01A1
|
$172,369
|
$172,369
|
SHUKLA, SANJEEV
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Triterpenoid Modulators of Inflammatory Driven Carcinogenesis
|
5R01CA157735-05
|
$315,408
|
$315,408
|
TOCHTROP, GREGORY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
S1P Lyase in colon cancer
|
5R01CA129438-08
|
$314,090
|
$78,523
|
SABA, JULIE
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
Novel Role of Honokiol in Preventing Cancer during Immune Suppression
|
1R21CA191735-01A1
|
$236,488
|
$236,488
|
PAL, SOUMITRO
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
|
5R01CA172896-03
|
$335,154
|
$335,154
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
1R01CA196854-01
|
$725,110
|
$725,110
|
ARMENIAN, SARO
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-32S1
|
$113,085
|
$4,523
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-32S2
|
$53,400
|
$2,136
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-32S3
|
$50,000
|
$2,000
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-32S4
|
$124,999
|
$5,000
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-32
|
$2,184,600
|
$87,384
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts
|
1R03CA186218-01A1
|
$81,186
|
$81,186
|
ABRAMS, JULIAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Increasing breast cancer chemoprevention in the primary care setting
|
5R01CA177995-02
|
$650,947
|
$650,947
|
CREW, KATHERINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S1
|
$120,000
|
$2,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S2
|
$60,000
|
$1,200
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S3
|
$125,000
|
$2,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S4
|
$157,133
|
$3,143
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-41
|
$3,792,720
|
$75,854
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanism of Action of Retinoic Acid Using CD38
|
5R01CA152870-05
|
$325,385
|
$325,385
|
YEN, ANDREW
|
CORNELL UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA006516-50S1
|
$122,500
|
$4,900
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S2
|
$50,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S3
|
$125,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S4
|
$200,000
|
$8,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S5
|
$62,500
|
$2,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-50
|
$11,162,542
|
$446,502
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-08
|
$2,185,000
|
$87,400
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INST
|
Total relevant funding to Chemoprevention for this search: $109,956,921
|